|
Q1 FY2026
As of Apr 4, 2026
|
Q4 FY2025
As of Jan 3, 2026
|
Q3 FY2025
As of Sep 27, 2025
|
Q2 FY2025
As of Jun 28, 2025
|
Q1 FY2025
As of Mar 29, 2025
|
Q4 FY2024
As of Dec 28, 2024
|
Q3 FY2024
As of Sep 28, 2024
|
Q2 FY2024
As of Jun 29, 2024
|
Q1 FY2024
As of Mar 30, 2024
|
Q4 FY2023
As of Dec 30, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jul 1, 2023
|
Q1 FY2023
As of Apr 1, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Oct 1, 2022
|
Q2 FY2022
As of Jul 2, 2022
|
Q1 FY2022
As of Apr 2, 2022
|
Q4 FY2021
As of Jan 1, 2022
|
Q3 FY2021
As of Oct 2, 2021
|
Q2 FY2021
As of Jul 3, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable net current | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accounts receivable net current | ||||||||||||||||||||
| Assets held-for-sale - (Note 8) | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Other current assets, held-for-sale - (Note 18) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Lease receivable, non-current | ||||||||||||||||||||
| Deferred costs and other contract assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangibles assets, net | ||||||||||||||||||||
| Customer relationships | ||||||||||||||||||||
| Acquired technologies | ||||||||||||||||||||
| Intangibles assets, net | ||||||||||||||||||||
| Total intangibles assets, net | ||||||||||||||||||||
| Trademarks - (Note 9) | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Other non-current assets, held-for-sale - (Note 18) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Deferred revenue and other contract liabilities, current | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Other current liabilities, held-for-sale - (Note 18) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Other non-current liabilities, held-for-sale - (Note 18) | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Preferred stock, $0.001 par value; 5.0 million shares authorized; 0 shares issued and outstanding | ||||||||||||||||||||
| Common stock, $0.001 par value; 100.0 million shares authorized; 52.4 million and 52.1 million shares issued and outstanding at April 4, 2026 and January 3, 2026, respectively | ||||||||||||||||||||
| Treasury stock, 22.0 million and 22.0 million shares at April 4, 2026 and January 3, 2026, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
